Navigation Links
Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2012 On Thursday, February 28, 2013, After Close of U.S.-Based Financial Markets
Date:2/13/2013

stigational drug candidate, which is being evaluated in Phase 3 clinical studies as a once- daily, oral tablet for the treatment of opioid-induced constipation.  This agreement also includes NKTR-119, an earlier stage development program that is a co-formulation of naloxegol and an opioid.  NKTR-181, a novel mu-opioid analgesic candidate for chronic pain conditions, is in Phase 2 development in osteoarthritis patients with chronic knee pain.  NKTR-192, a novel mu-opioid analgesic in development to treat acute pain is in Phase 1 clinical development.  In oncology, etirinotecan pegol (NKTR-102) is being evaluated in a Phase 3 clinical study (the BEACON study) for the treatment of metastatic breast cancer and is also in Phase 2 studies for the treatment of ovarian and colorectal cancers.

Nektar's technology has enabled eight approved products in the U.S. or Europe through partnerships with leading biopharmaceutical companies, including Affymax's OMONTYS® for anemia, UCB's Cimzia® for Crohn's disease and rheumatoid arthritis, Roche's PEGASYS® for hepatitis C and Amgen's Neulasta® for neutropenia.  Additional development-stage products that leverage Nektar's proprietary technology platform include Baxter's BAX 855, a long-acting PEGylated rFVIII program, which is in Phase 3 clinical development.

Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India.  Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.


'/>"/>
SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Nektar Therapeutics Announces Private Placement of $125 Million of Senior Secured Notes Due in 2017
2. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 30th Annual J.P. Morgan Healthcare Conference in San Francisco, CA
3. AMRI and Codexis Announce Technology Collaboration
4. Bioassociate Announces Initiation of Coverage on Oramed Pharmaceuticals, Inc.
5. AMRI Announces Fourth Quarter 2012 Adjusted EPS of $0.17
6. Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2012 Results and Conduct Conference Call on Tuesday, February 26, 2013
7. Quantum Materials Corporation Announces Non-Heavy Metal (Cadmium-Free) Tetrapod Quantum Dots
8. The In View Series Announces Plans for a New Series on 3D-Printing
9. Qualitas Health and Valicor Renewables Announce Strategic Partnership to Commercialize Algae-Based Omega-3 Supplements
10. Elsevier Announces the Launch of a New Journal: Journal of Forensic Radiology and Imaging
11. The In View series hosted by Larry King Announces plans for a series on Autoimmune Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Proove Biosciences , the commercial and research ... the association between specific genes and patients’ predisposition to ... Health Congress’ 27th Annual Scientific Program in Orlando, ... of ‘Embracing Change.’ Mental health, and healthcare as a ... challenges presented by the Affordable Care Act to the ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 Proove ... medicine, presented industry leading research and data on the ... at the American Academy of Pain Management’ ... in Phoenix, Arizona at the , Proove ... between gender and genetic predisposition to opioid misuse risk ...
(Date:9/23/2014)... Calif. , Sept. 23, 2014 ... in India devoted to genome-based research ... Biomedical Genomics (NIBMG) is taking a bite out of ... cancer among males in India with ... storage solutions from DataDirect Networks (DDN). , To fuel ...
(Date:9/23/2014)... 2014   GenoSpace , a precision medicine software ... to enable the broad use of genomic data in ... been awarded Phase I of a Fast Track Small ... of Health (NIH) to enable enhanced data access and ... http://photos.prnewswire.com/prnh/20140922/147649 During the past decade, ...
Breaking Biology Technology:Proove Biosciences Will Be Exhibiting New Genetic Research at the 27th Annual US Psych Congress Scientific Program 2Proove Biosciences Will Be Exhibiting New Genetic Research at the 27th Annual US Psych Congress Scientific Program 3Proove Biosciences Will Be Exhibiting I.M.P.L.O.R.E Study at the American Academy of Pain Management 25th Annual Meeting 2Proove Biosciences Will Be Exhibiting I.M.P.L.O.R.E Study at the American Academy of Pain Management 25th Annual Meeting 3National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 2National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 3National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 4National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 5GenoSpace Awarded Fast Track SBIR Grant to Enable Data Access and Cohort Construction for Biorepositories 2
... ... its first relaunch, and came out as a beta. In this relaunch they have focused on ... get more relevant results. They have tried to get the users to get and give a ... , ...
... POMPEY, France, September 17 Novasep is ... - France, specialized in the development,and manufacturing of ... "Potent Compound Safety Certification" from SafeBridge(R),Consultants, Inc. , ... Safety Certification program verifies,Novasep,s performance in the management, ...
... SCOTTSDALE, Ariz., Sept. 17 MedTrust Online, a ... options for challenging patient cancer cases, has surpassed 5,000 ... Online also announced today that world-renowned oncologist Dr. Henry ... advisors. , , "5,000 users is ...
Cached Biology Technology:ePDF is Happy to Announce that ePDF has Completed its First Relaunch, and has Come Out as a Beta 2Novasep Gains SafeBridge(R) "Potent Compound Safety Certification" for its Le Mans Facility 2Novasep Gains SafeBridge(R) "Potent Compound Safety Certification" for its Le Mans Facility 3MedTrust Online Surpasses 5,000 Registered Users and Adds Dr. Henry Friedman to Oncology Advisory Board 2
(Date:9/23/2014)... moving body relies on an orchestrated response of bones, joints, ... literally the geometry of a critical part like ... just a footfall error at the root of one of ... cruciate ligament tear. In fact, size of the femoral ... and volume of the ACL combine to influence the ...
(Date:9/23/2014)... MADISON, Wis. A multidisciplinary team at the University ... creating a faster, more affordable way to screen for ... development. , The National Institutes of Health (NIH) announced ... 11 universities receiving support to continue the promising work ... program. The team will receive approximately $7 million over ...
(Date:9/23/2014)... Health will award funds to support the next phase ... improve ways of predicting drug safety and effectiveness. Researchers ... human tissue chips and combine them into an integrated ... human body. Led by the National Center for Advancing ... at $17 million in 2014 with additional support over ...
Breaking Biology News(10 mins):Does size matter? MRI imaging sheds light on athletes most at risk for severe knee injury 2Does size matter? MRI imaging sheds light on athletes most at risk for severe knee injury 3UW-Madison team developing 'tissue chip' to screen neurological toxins 2UW-Madison team developing 'tissue chip' to screen neurological toxins 3NIH funds next phase of Tissue Chip for Drug Screening program 2NIH funds next phase of Tissue Chip for Drug Screening program 3NIH funds next phase of Tissue Chip for Drug Screening program 4
... Leading scientists, physicians, and veterinarians are uncovering new links ... implications for human health. , "Marine mammals are providing ... says Paul Sandifer, Chief Scientist for the new Oceans ... and Atmospheric Administration (NOAA). "There is mounting evidence ...
... there's a constant shuffling of genetic material going ... via ocean-dwelling viruses, scientists report this week in ... Sallie Chisholm and her colleagues at the Massachusetts ... new facet of evolution and helping scientists see ...
... gene responsible for making embryos male and forming the ... by Parkinson's disease. Published in the Feb. 21 ... why more men than women develop the degenerative disorder, ... 1.5 times more likely to develop Parkinson's disease than ...
Cached Biology News:Marine mammals are on the frontline of failing ocean health 2Marine mammals are on the frontline of failing ocean health 3Marine mammals are on the frontline of failing ocean health 4Marine mammals are on the frontline of failing ocean health 5Marine mammals are on the frontline of failing ocean health 6Scientists discover interplay between genes and viruses in tiny ocean plankton 2UCLA scientists find male gene in brain area targeted by Parkinson's 2
... bottoms,• Nonreversible lids with ... contamination,• Individual alphanumerical codes ... footprint for ease in ... cell attachment,• Sterilized by ...
... is a G1 cyclin required for G1-phase ... a proto-oncogene. cyclin D2 can phosphorylate ... Species Reactivity: Human, Mouse, and Rat. ... is particularly well suited for neutralization of ...
... combines shaking and rocking for maximal fluid movement. ... mm stainless steel or acrylic platform, it is ... operation. The platform angle is easily adjusted from ... action and rotation speed of platform is adjusted ...
... PROTEAN II xi 2-D system runs both gel dimensions ... tube gels can be separated in a single run ... cooling core in much the same manner as the ... the second-dimension slab gels may be cast in the ...
Biology Products: